CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel treatment for arthritis using gold nanoparticles to deliver therapeutic RNA directly to affected joints. It seeks to provide a long-term solution to alleviate symptoms and address the underlying causes of the disease.
Arthritis is a common metabolic and immune associate disease that causes chronic pain and inflammation in a joint.
Approximately312 million people are affected by arthritis globally.
It affects adults of all ages, both sexes, and all races and ethnicities, but theprevalence in women is more than in men.
Professional organizations have established many arthritis treatment regimens andmanagement guidelines; in those nonsteroidal anti-inflammatory drugs (NSAIDs), steroids and biologicals are the ma…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Portugal, Braga
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.